Saturday January 19, 2019 17:46

Heathcare Press Release : 27 Sep 2017

Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan Heathcare—27 Sep 17

- First-ever treatment indicated for curatively unresectable Merkel cell carcinoma (MCC) and first anti-PD-L1 to be available in Japan - Japanese Ministry of Health, Labour and Welfare (MHLW) decision based on Javelin Merkel 200 study, the largest